Tuesday, November 11, 2025
HomeIndustriesBiotechnology

Biotechnology

Arcellx Announces Clinical Hold for its iMMagine-1 Phase 2 Clinical Program

Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, announced that...

Vial Partners with Nielsen BioSciences, Inc. in Phase III Clinical Trial for the Treatment of Common Warts

Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with Nielsen BioSciences, Inc. (Nielsen), a privately-held biopharmaceutical company based in San Diego, CA, to study...

Mission Bio’s Tapestri Platform Demonstrates Highly Robust And Reproducible Data

Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced successful results of validation studies of the Tapestri Platform. Data from a...

Food-Drug Interactions Could be Impactful for Some Lung Cancer Patients According to New Study in JNCCN

New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to...

HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson’s Disease

HanAll Biopharma and Daewoong Pharmaceutical announced the expansion of their open collaboration strategy by investing in Vincere Biosciences, a Cambridge, MA-based company developing therapeutics...
0FansLike
0FollowersFollow
spot_img

Hot Topics